Vanguard Equity-Income Inv (VEIPX)
Nasdaq • Currently up 0.39 (+0.78%) in today's trading session
1 member of Congress has disclosed 1 trade in Vanguard Equity-Income Inv (VEIPX) via STOCK Act filings. The most recent disclosure was a sale by Greg Gianforte on 10 August 2017. Aggregate disclosed activity totals roughly $32.5K in sales (midpoint estimates from bracketed disclosure amounts).
Vanguard Equity-Income Inv is currently trading at $50.47, positioned at 98% of its 52-week range ($43.86 – $50.59).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Past Performance is not an indication of future results.
Vanguard Equity-Income Inv Price History and Technical Analysis
Congressional Trading Activity for VEIPX
| Greg Gianforte | 10 Aug 2017 | 13 Aug 2018 | Sale | Stock | $15,001 - $50,000 | N/A |
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
Frequently Asked Questions about VEIPX
- Which members of Congress have traded VEIPX?
- 1 member of Congress has disclosed 1 trade in Vanguard Equity-Income Inv (VEIPX) under the STOCK Act: Greg Gianforte.
- When was VEIPX most recently disclosed by Congress?
- The most recent VEIPX disclosure was a sale by Greg Gianforte on 10 August 2017.
- What is the total disclosed congressional trading volume for VEIPX?
- Members of Congress have disclosed approximately $32.5K in VEIPX sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
- How can I track new congressional trades in VEIPX?
- This VEIPX page updates as soon as new STOCK Act disclosures are filed for Vanguard Equity-Income Inv. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track VEIPX in Congress
See when politicians buy or sell this stock